✕
Login
Register
Back to News
Cellebrite DI Affirms FY2026 Sales Guidance of $565.000M-$571.000M vs $566.402M Est
Benzinga Newsdesk
www.benzinga.com
Neutral 44.5%
Neg 0%
Neu 44.5%
Pos 0%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment